TP53 and neoplasm: This is elegantly demonstrated by the Hu lab in HUPKI mice (human p53 knock-in mice), where mice with p53SNP72Pro developed shorter tumour-associated lifespan, compared with those with SNP72Arg, despite similar tumour incidence.